Patient and doctor perspectives on incorporating smoking cessation into tuberculosis care in Beijing, China
OBJECTIVE: To describe perspectives of patients and physicians regarding the incorporation of smoking cessation interventions as part of TB treatment.
DESIGN: Seven focus groups were conducted with 39 patients and 17 physicians.
RESULTS: Patients were more receptive to physicians' advice to quit smoking due to increased concerns about their health after becoming ill with TB. However, patients indicated that they might start smoking again after they recovered from TB. Patients' attempts to quit smoking may have been inhibited by exposure to smoking at the TB facility. Physicians had low levels of knowledge regarding the effect of smoking on TB. Many doctors, particularly those who smoked, did not view smoking cessation as an integral part of TB treatment.
CONCLUSION: Despite the presence of a ‘teachable moment’, TB patients experience significant barriers to quitting smoking. Patient education in TB treatment programs should address the specific effects of smoking on TB and the general health benefits of cessation. Smoke-free policies should be strictly enforced in TB facilities. Successful integration of smoking cessation interventions within TB treatment regimens may require that providers adopt smoking cessation as an essential part of TB treatment.
Keywords: China; qualitative research; smoking cessation; tobacco control; tuberculosis
Document Type: Research Article
Affiliations: 1: Joint Doctoral Program in Global Health, San Diego State University/University of California, San Diego, California, USA 2: Beijing Institute of Respiratory Medicine, Beijing Chao-Yang Hospital, Capital Medical University, WHO Collaborating Center for Tobacco or Health, Beijing, China 3: Beijing Chest Hospital, Capital Medical University, Beijing, China 4: Peking Union Medical College, Beijing, China 5: Graduate School of Public Health, San Diego State University, San Diego, California, USA
Publication date: 01 January 2012
The International Journal of Tuberculosis and Lung Disease (IJTLD) is for clinical research and epidemiological studies on lung health, including articles on TB, TB-HIV and respiratory diseases such as COVID-19, asthma, COPD, child lung health and the hazards of tobacco and air pollution. Individuals and institutes can subscribe to the IJTLD online or in print – simply email us at [email protected] for details.
The IJTLD is dedicated to understanding lung disease and to the dissemination of knowledge leading to better lung health. To allow us to share scientific research as rapidly as possible, the IJTLD is fast-tracking the publication of certain articles as preprints prior to their publication. Read fast-track articles.
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites
- Access Key
- Free content
- Partial Free content
- New content
- Open access content
- Partial Open access content
- Subscribed content
- Partial Subscribed content
- Free trial content